Safety And Tolerability Of Extended-Release Guaifenesin In Patients With Cough, Thickened Mucus And Chest Congestion Associated With Upper Respiratory Tract Infection

PURPOSE: An extended-release (ER) formulation of the expectorant guaifenesin has recently been launched in India for the treatment of productive cough accompanied by mucus (phlegm). Although the safety profile of ER guaifenesin marketed in the USA is well documented, there were limited safety data a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripathi, Sanjay, Nikhare, Ashish, Sharma, Gaurav, Shea, Tim, Albrecht, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791405/
https://www.ncbi.nlm.nih.gov/pubmed/31632154
http://dx.doi.org/10.2147/DHPS.S222109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791405/
https://www.ncbi.nlm.nih.gov/pubmed/31632154
http://dx.doi.org/10.2147/DHPS.S222109

Ejemplares similares